|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.35 TWD | -7.90% |
|
+5.11% | +31.39% |
| May. 31 | DIVA Laboratories, Ltd. Announces Cash Dividend, Payable on July 18, 2024 | CI |
| May. 31 | DIVA Laboratories, Ltd. Announces Change of Audit Committee and Remuneration Committee | CI |
DIVA Laboratories, Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 222.39 million compared to TWD 248.8 million a year ago. Net income was TWD 24.37 million compared to TWD 21.42 million a year ago.
Basic earnings per share from continuing operations was TWD 0.42 compared to TWD 0.37 a year ago. Diluted earnings per share from continuing operations was TWD 0.41 compared to TWD 0.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.39% | 94.46M | |
| +26.73% | 32.79B | |
| -1.16% | 10.83B | |
| +27.16% | 8.41B | |
| +0.70% | 4.32B | |
| -2.48% | 4.16B | |
| -15.62% | 4.08B | |
| -18.11% | 3.87B | |
| -0.30% | 3.36B | |
| -33.15% | 2.44B |
DIVA LABORATORIES, LTD. 
